Microeconomics
- All
- AI
- Markets
- Macroeconomics
As the Canadian market continues to navigate through a landscape of easing trade tensions and cautious monetary policy adjustments, investors are keeping a close eye on opportunities that may arise from these evolving conditions. In this context, identify
Woldenberg, who runs two educational-toy businesses near Chicago, says the BubblePlush Yoga Ball Buddies, designed to help kids control their emotions, has been hit especially hard by Trump’s fluctuating global tariffs.
At Yahoo Finance Invest, an influential lineup of leaders across business, politics, and finance will convene to discuss what's next in markets, AI, cryptocurrency, and more.
Analysts have recently adjusted their outlook on Freshpet stock, modestly decreasing the company's fair value estimate from $79.31 to $76.06. This change comes as industry trends evolve and the pet food maker faces a mix of growth opportunities and rising
Bokusgruppen (OM:BOKUS) reported robust earnings momentum, with profits climbing 58.9% in the recent period and net profit margins rising to 3% from 2.1% last year. Over the past five years, earnings have grown at an impressive 18.8% annual rate. However,
Ajinomoto (TSE:2802) shares have drawn fresh attention as investors revisit the company’s performance this month. While there has not been any single headline event, several market watchers are observing how its ongoing growth trends might influence futur
Worldline’s stock narrative has taken a notable turn, with consensus analyst price targets dropping sharply from €3.56 to €3.17. This downward revision comes as analysts grow more cautious, as they weigh persistent market headwinds against opportunities f
President Donald Trump said on Saturday he was increasing tariffs on Canada by an additional 10% \\
Canon Marketing Japan (TSE:8060) reported annual earnings growth of 5.3%, a pace that falls below its five-year average of 10.2% per year. Net profit margin held steady at 5.9%, unchanged from last year, signaling stable profitability without margin expan
AbbVie stock has seen its consensus analyst price target rise modestly from $232.78 to $237.48 per share. This change reflects evolving views in the wake of recent company updates. The shift is largely driven by extended product exclusivity and changing a
On-chain data shows Ethereum whales and sharks have bought over 218,000 ETH, worth roughly $870 million, after previously selling.